Health News GV’s AI Health Bets: Tempus vs. Forward & Flatiron Strategy By Editorial Team Jul 17, 2026
Health News Digital Health’s AI Boom: Where 54% of Billion Dollar Capital Went By Editorial Team Jul 16, 2026
Health News Aidoc’s 31 FDA Clearances: Justifying a Half-Billion Dollar AI Premium? By Editorial Team Jul 16, 2026
Chronic Conditions Oak HC/FT: De-Risking Health-Tech VC in a Volatile Market By Editorial Team Jul 16, 2026
Health News Tiger Global’s AI Health Bets: Viz.ai Win vs. Olive AI Loss By Editorial Team Jul 16, 2026
Health News Olive AI’s $4 Billion Collapse: A Due Diligence Masterclass By Editorial Team Jul 15, 2026
Chronic Conditions Omada IPO: Digital Chronic Care’s Billion Dollar Bellwether By Editorial Team Jul 15, 2026
Health News HeartFlow’s IPO: Cardiac AI’s Path to Billion Dollar Exits By Editorial Team Jul 15, 2026
Health News Bain Capital’s HeartFlow Bet: A Blueprint for Cardiac AI Exits? By Editorial Team Jul 15, 2026
Health News Oak Street Health: Unpacking a Billion Dollar VBC Multiple By Editorial Team Jul 15, 2026
